Literature DB >> 2187072

Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods.

H Andreassen1, H Bohr, J Bohr, S Brunak, T Bugge, R M Cotterill, C Jacobsen, P Kusk, B Lautrup, S B Petersen.   

Abstract

A neural network computer program, trained to predict secondary structure of proteins by exposing it to matching sets of primary and secondary structures from a database, was used to analyze the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 from their amino acid sequences. The results are compared to those obtained by the Chou-Fasman analysis. Two alpha-helical sequences corresponding to the putative fusigenic domain and to the transmembrane domain of gp41 could be predicted, as well as a possible binding site between p17 and gp41. On the basis of the secondary structure predictions, a three-dimensional model of p17 was constructed. This model was found to represent a stable conformation by an analysis using an energy-minimization program. The model predicts that p17 is attached to the membrane only by the acylated N-terminus, in analogy with the N-terminus of the gag protein of other retroviruses and also with the src oncogene protein p60src. The intracellular C-terminal part of gp41 may act as a receptor by electrostatic interaction with p17.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187072

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  16 in total

1.  Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

Authors:  S S Chen; S F Lee; C T Wang
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.

Authors:  Maria A De Francesco; Manuela Baronio; Simona Fiorentini; Costantino Signorini; Carlo Bonfanti; Claudio Poiesi; Mikulas Popovic; Manuela Grassi; Emirena Garrafa; Luisa Bozzo; George K Lewis; Stefano Licenziati; Robert C Gallo; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-08       Impact factor: 11.205

3.  Topological maps of protein sequences.

Authors:  E A Ferrán; P Ferrara
Journal:  Biol Cybern       Date:  1991       Impact factor: 2.086

4.  A neural network application to classification of health status of HIV/AIDS patients.

Authors:  N K Kwak; C Lee
Journal:  J Med Syst       Date:  1997-04       Impact factor: 4.460

5.  Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  D H Gabuzda; A Lever; E Terwilliger; J Sodroski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

6.  Characterization of the water defect at the HIV-1 gp41 membrane spanning domain in bilayers with and without cholesterol using molecular simulations.

Authors:  Michelle K Baker; Vamshi K Gangupomu; Cameron F Abrams
Journal:  Biochim Biophys Acta       Date:  2014-01-16

7.  Self-organized neural maps of human protein sequences.

Authors:  E A Ferrán; B Pflugfelder; P Ferrara
Journal:  Protein Sci       Date:  1994-03       Impact factor: 6.725

8.  Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.

Authors:  T H Bugge; B O Lindhardt; L L Hansen; P Kusk; E Hulgaard; K Holmbäck; P J Klasse; J Zeuthen; K Ulrich
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

9.  The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein.

Authors:  Kosuke Miyauchi; A Rachael Curran; Yufei Long; Naoyuki Kondo; Aikichi Iwamoto; Donald M Engelman; Zene Matsuda
Journal:  Retrovirology       Date:  2010-11-13       Impact factor: 4.602

10.  Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.

Authors:  N Chazal; C Carrière; B Gay; P Boulanger
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.